Phoenix Biotech Acquisition Corp. (PBAXU) is a publicly traded company in the Financial Services sector, operating within the Shell Companies industry. The company is headquartered in Oakland, CA, United States. The current CEO is Christopher B. Ehrlich.
PBAXU has IPO date of 2021-10-06, listed on the NASDAQ Global Market, a market capitalization of $36.54M.
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
